Across TCGA pan-cancer cohorts, CDPF1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CDPF1 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher CDPF1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated CDPF1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

CCRCC and HNSC are the cancer types where CDPF1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	All	0.908	0.677	.027	3	view →
HNSC	DFS	Quartile	III,IV	0.782	1.000	.024	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CDPF1 tumor-vs-normal RNA expression · all CDPF1 data types